Market capitalization | $11.34m |
Enterprise Value | $94.32m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 24.63 |
P/S ratio (TTM) P/S ratio | 2.96 |
P/B ratio (TTM) P/B ratio | negative |
Revenue growth (TTM) Revenue growth | 378.63% |
Revenue (TTM) Revenue | $3.83m |
As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.
3 Analysts have issued a PAVmed, Inc. forecast:
3 Analysts have issued a PAVmed, Inc. forecast:
Jun '24 |
+/-
%
|
||
Revenue | 3.83 3.83 |
379%
379%
|
|
Gross Profit | -5.32 -5.32 |
37%
37%
|
|
EBITDA | -57 -57 |
30%
30%
|
EBIT (Operating Income) EBIT | -60 -60 |
30%
30%
|
Net Profit | -58 -58 |
27%
27%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
PAVmed, Inc. is a medical device company, which develops and commercializes a pipeline of medical products. Its product portfolio includes DisappEAR, PORTIO, Caldus, Carpx, NextCath, and NextFlo. The firm conducts its operations in four divisions: GI Health, Minimally Invasive Interventions, Infusion Therapy and Emerging Innovations. The GI Health division consists of Edouard Esophageal DNA Test, EsoCheck Esophageal Cell Collection Device, and EsoCure Esophageal Ablation Device with Caldus Technology. The Minimally Invasive Interventions division consists of CarpX, which is a patented, single-use disposable, minimally invasive device designed to treat carpal tunnel syndrome. The Infusion Therapy division consists of PortIO, which is a novel, patented, implantable, intraosseous vascular medical device; and NextFlo, which is designed to deliver gravity-driven infusions independent of the height of the IV bag. The Emerging Innovations division refers to a diversified and expanding portfolio of innovative products designed to address unmet clinical needs across a broad range of clinical conditions. The company was founded on June 26, 2014 and is headquartered in New York, NY.
Head office | United States |
CEO | Lishan Aklog |
Employees | 107 |
Founded | 2014 |
Website | www.pavmed.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.